PLx Pharma Winddown Corp. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
PLx Pharma Winddown Corp. reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of $11.69 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-11.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-08-11
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was $13.69M.
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$2.00M, a 149.88% decline year-over-year.
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $11.00M, a 91981.03% increase year-over-year.
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was $4.01M.
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was $27.02M.
- PLx Pharma Winddown Corp. net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$26.96M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month |
|---|---|---|---|---|
| 2017-06-30 | $13.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $11.69M 10-Q · filed 2017-08-11 | $22.69M derived: sum of 3 quarters · filed 2017-08-11 | |
| 2017-03-31 | -$2.00M 10-Q · filed 2017-04-17 | $9.00M derived: sum of 2 quarters · filed 2017-04-17 | ||
| 2016-12-31 | $11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-01-20 | $27.02M 10-K · filed 2017-01-20 | ||
| 2016-09-30 | $16.02M 10-Q · filed 2016-11-09 | |||
| 2016-03-31 | $4.01M 10-Q · filed 2017-04-17 | $4.02M derived: sum of 2 quarters · filed 2017-04-17 | -$10.96M derived: sum of 3 quarters · filed 2017-04-17 | |
| 2015-12-31 | $11.95K derived: 10-K 12 month − 10-Q 9 month · filed 2017-01-20 | -$14.97M derived: sum of 2 quarters · filed 2017-01-20 | -$26.96M 10-K · filed 2017-01-20 | |
| 2015-09-30 | -$14.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | -$26.97M 10-Q · filed 2016-11-09 | ||
| 2015-06-30 | -$11.99M 10-Q · filed 2015-08-12 |